Filing Details
- Accession Number:
- 0001209191-16-119153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-11 16:42:40
- Reporting Period:
- 2016-05-09
- Filing Date:
- 2016-05-11
- Accepted Time:
- 2016-05-11 16:42:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649689 | J James Vaughn | 301 Penobscot Drive Redwood City CA 94063 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-09 | 2,000 | $18.89 | 33,255 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-05-09 | 2,000 | $28.00 | 31,255 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-09 | 2,000 | $0.00 | 2,000 | $18.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,997 | 2016-11-30 | No | 4 | M | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2015.
- Represents actual sale price.
- Includes an aggregate of 18,280 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.